Moreover, the expression levels of mRNAs such as SAMD5 (Li et al., 2019) and ZNF154 (Zhang et al., 2018) served as prognostic biomarkers for predicting the risk of BCR in PCa. This evidence concerns the gene BCR and posterior cortical atrophy.